Abstract
The quadrivalent (types 6/11/16/18) human papillomavirus (HPV) vaccine, Gardasil, has demonstrated efficacy against persistent HPV infection and associated anogenital disease in males. The goal of this Phase II trial was to establish the immunogenicity and safety of Gardasil among mid-adult men ages 27-45 years. One hundred and fifty men from Tampa, FL, US, and Cuernavaca, Mexico who met eligibility criteria (male, 27-45 years old, completed four years of follow-up in the HPV Infection in Men (HIM) natural history study) were enrolled. Subjects completed four visits over seven months, with Gardasil administered at Day 1 and Months 2 and 6. Sera were collected at Day 1 (pre-vaccination) and Month 7 (one month post-dose three). Anti-HPV6, 11, 16, and 18 IgG levels were determined by competitive Luminex immunoassay. 100% of men seroconverted to each of the four HPV vaccine components, and the vaccine was generally well-tolerated. Antibody responses to vaccine did not differ by age group or sexual orientation, regardless of HPV type, and were significantly higher at Month 7 among men who entered the trial seropositive for HPV 6 or 11. The immune response to HPV vaccination in men ages 27-45 was comparable to that observed in younge...Continue Reading
References
Oct 31, 2002·The Journal of Infectious Diseases·Katherine M StoneWilliam C Reeves
Jan 11, 2003·Clinical and Diagnostic Laboratory Immunology·David OpalkaMark T Esser
Sep 23, 2006·The Journal of Infectious Diseases·Eileen F DunneAnna R Giuliano
Oct 24, 2007·The Journal of Infectious Diseases·Jeffrey M PartridgeLaura A Koutsky
Jul 29, 2008·The Journal of Infectious Diseases·Anna R GiulianoRobin B Harris
Dec 15, 2010·The Journal of Infectious Diseases·Alan G NyitrayAnna R Giuliano
Feb 4, 2011·The New England Journal of Medicine·Anna R GiulianoDalya Guris
Mar 4, 2011·Lancet·Anna R GiulianoDanelle Smith
Oct 28, 2011·The New England Journal of Medicine·Joel M PalefskyElizabeth I O Garner
Nov 30, 2011·Cancer Research·Beibei LuAnna R Giuliano
Dec 14, 2011·Clinical and Vaccine Immunology : CVI·Richard J HillmanElizabeth I O Garner
Feb 7, 2012·Vaccine·Brandon BrownNeal Halsey
Jul 6, 2013·Lancet·Aimée R KreimerAnna R Giuliano
Nov 20, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Anil K ChaturvediMaura L Gillison
Jul 22, 2014·International Journal of Cancer. Journal International Du Cancer·Anna R GiulianoSilvia Franceschi
Sep 6, 2014·Lancet·S Rachel SkinnerGary Dubin
Citations
Jun 18, 2016·CA: a Cancer Journal for Clinicians·Philippe E SpiessAnna R Giuliano
Jun 23, 2016·The Journal of Infectious Diseases·Suzette M MatthijsseSake J de Vlas
Aug 12, 2016·The Journal of Infectious Diseases·Ligia A PintoAnna R Giuliano
Dec 28, 2017·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Anastasia PhillipsKristine Macartney
Dec 7, 2017·Oncoimmunology·Stefano PieriniLorenzo Galluzzi
May 6, 2019·Human Vaccines & Immunotherapeutics·Mary Roz TimbangMichael G Moore
Mar 11, 2020·Journal of Cutaneous Medicine and Surgery·Alex DerstenfeldIvan V Litvinov
Oct 29, 2019·Human Vaccines & Immunotherapeutics·Betania Allen-LeighEduardo Cesar Lazcano-Ponce
Jun 3, 2020·Cancer Medicine·Joël Fokom DomgueSanjay Shete
Sep 18, 2020·Journal of Pharmacy Practice·Michelle R PaulsenShubha Bhat
Aug 31, 2019·Epidemiology and Infection·Reyna Lizette Pacheco-DomínguezMalaquías López-Cervantes
Jul 20, 2017·AIDS Research and Therapy·Carmen Hidalgo-TenorioJuan Pasquau
May 10, 2018·The Cochrane Database of Systematic Reviews·Marc ArbynPierre Pl Martin-Hirsch
Nov 30, 2018·Frontiers in Immunology·Maryam DadarWanpen Chaicumpa
Nov 23, 2020·Preventive Medicine·Ramandip GrewalUNKNOWN OHTN Cohort Study Team
Jan 28, 2021·Viruses·Carmen Hidalgo-TenorioJessica Ramírez-Taboada
Jul 22, 2017·AIDS Research and Therapy·Carmen Hidalgo-TenorioJuan Pasquau
May 14, 2021·Patient Education and Counseling·Christopher W WheldonErika L Thompson
May 26, 2021·Human Vaccines & Immunotherapeutics·J HoesH E de Melker
Jun 29, 2021·Reumatología clinica·Íñigo Rúa-Figueroa Fernández de LarrinoaMaría Correyero Plaza
Aug 6, 2021·Pediatric Dermatology·Muhammad Hyder Junejo, Umar Ahmad Sheikh
Aug 11, 2021·Vaccine·Cheryl N MillerAnna R Giuliano